No Data
No Data
Teyi Pharmaceutical GroupLtd's (SZSE:002728) One-year Decline in Earnings Translates Into Losses for Shareholders
teyi pharmaceutical group (002728.SZ): The company's production line currently does not use siasun robot&automation.
teyi pharmaceutical group (002728.SZ) stated on the investor interaction platform that the company's production line currently does not use robots.
Teyi Pharmaceutical Group (002728.SZ) has repurchased 2.46% of shares, spending approximately 92.67 million yuan.
teyi pharmaceutical group (002728.SZ) announced that as of August 31, 2024, the company has passed the Shenzhen Securities...
Retail Investors Among Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Largest Stockholders and Were Hit After Last Week's 9.0% Price Drop
Teyi Pharmaceutical Group (002728.SZ): Its Acetaminophen and Ibuprofen tablets can be used for symptoms such as fever and muscle soreness in production and sales.
Teyi pharmaceutical group (002728.SZ) stated on the investor interactive platform on August 16th that smallpox patients usually have symptoms such as fever, muscle pain, and rashes. Currently, the company's production and sales of acetaminophen tablets and ibuprofen tablets can be used for fever, muscle soreness and other symptoms, and ribavirin granules can be used for herpes virus infection. When smallpox is severe, it can endanger the patient's life. It is recommended that patients receive treatment and medication under the guidance of a physician.
Teyi Pharmaceutical Group (002728.SZ) continues to increase its marketing efforts for high-potential products such as Skin Disease Xue Du Wan and Blood Sugar Reducing Shu Wan with a large market capacity.
On August 6th, Gelunhui reported that Teyi Pharmaceutical Group (002728.SZ) stated in an investor relations activity that in order to enhance the company's core competitiveness, the management continues to increase the market promotion efforts of potential varieties such as Skin Disease and Blood Toxin Pills and Hypoglycemic Comfort Pills with large market capacity based on the sales promotion of Zhikebao Tablets. Currently, the market feedback of the Skin Disease and Blood Toxin Pills and Hypoglycemic Comfort Pills two potential varieties is good. Against the backdrop of strong support from national industrial policies for the development of traditional Chinese medicine industry, and given the large market potential of the Skin Disease and Blood Toxin Pills and Hypoglycemic Comfort Pills, the company has cultivated the above varieties as major varieties after Zhikebao Tablets.
No Data
No Data